arrow
A

Adolfo Favaretto

aulss 2 marca trevigiana
H指数:41
被引数:7,620

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry
2025-12-240
OA
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients

A-BRAVE试验:一项使用抗PD-L1药物avelumab治疗高风险三阴性早期乳腺癌患者的III期随机试验

2025-08-280
OAAI
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

影响年轻乳腺癌患者5年坚持辅助内分泌治疗的因素

BREAST
IF7.9
2024-10-010
OAAI
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database

非小细胞肺癌中的MET外显子14跳跃突变: 来自意大利生物标志物图谱数据库的真实数据

2024-09-010
OAAI
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients
2024-03-054
OAAI
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication

在意大利的同情使用计划中接受伊匹单抗和纳武单抗治疗的转移性肾细胞癌患者的伴随药物预后评分: 简要交流

2022-11-043
OAAI
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland
2022-06-103
PRE
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
2022-05-013
OAAI
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
2021-04-0114
OAAI
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
2018-11-2240
PREAI
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

免疫微环境在小细胞肺癌中的作用: PD-L1表达的分布和FOXP3-positive肿瘤浸润淋巴细胞的预后作用

2018-09-0195
PREAI
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program
2018-05-1810
PREAI
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
2017-07-0244
OAAI
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

厄洛替尼和贝伐单抗治疗晚期非小细胞肺癌并激活EGFR突变 (BELIEF): 一项国际性、多中心、单臂、2期临床试验

2017-05-01175
PREAI
The role of BRCA1 and AEG1 mRNA expression in advanced non-small-cell lung cancer (NSCLC) patients (p) with EGFR activating and pretreatment T790M mutations receiving the combination of erlotinib plus bevacizumab (E plus B) in the BELIEF trial
2016-07-150
PRE